NASDAQ
ALX Oncology Holdings Inc. (ALXO)
♥ 450 Thanks from members
ALX Oncology Holdings Inc. (ALXO) exhibits compressed micro-cap valuation trading between $1.58 and $2.21, buoyed by a Q1 2026 EPS beat of -$0.146 against a -$0.1979 consensus estimate, despite lingering clinical-stage biotech volatility and cautious market sentiment.